This website uses cookies to enhance your browsing experience, improve site performance, and gather analytics. By selecting 'Accept,' you consent to these cookies as described in our Privacy Policy.

Dexmedetomidine Versus Dexmedetomidine With Ketamine in Mechanically Ventilated ARDS Patients

Sponsored by Benha University

About this trial

Last updated 2 years ago

Study ID

RC 37-5-2023

Status

Recruiting

Type

Interventional

Phase

Phase 4

Placebo

No

Accepting

18-75 Years
18+ Years
All
All

Not accepting

Not accepting
Healthy Volunteers

Trial Timing

Ended a year ago

What is this trial about?

The goal of this clinical trial study is to compare dexmedetomidine versus the combination of dexmedetomidine with ketamine in hemodynamic changes and sedative effects in ARDS patients who are in need of mechanical ventilation. The main question[s] it aims to answer are: - [question 1]: Which dose that get the target in sedation, single and combined drugs? - [question 2]: In which drug group that hemodynamic did not affect Participants will be patients with ARDS that will be divided into two group the first ont will receive dexmedetomidine 0.5 µg/kg/h mixed with ketamine 0.5 mg/kg/h and the second one will receive dexmedetomidine at 0.5 µg/kg/h infusion only. In both the groups, studied drugs will be titrated to achieve target sedation.

What are the participation requirements?

Yes

Inclusion Criteria

- patients with ARDS with the following:

- Those whose duration of endotracheal intubation was > 120 h
- those whose ages were 18- 70 years old
- those with acute physiology and chronic health evaluation (APACHE) II scores > 12 points.
No

Exclusion Criteria

- patients with a history of allergy to ketamine or dexmedetomidine

- Pregnant women,

- patients in the early stage of recovery,

- patients with unstable hemodynamics, bradycardia, sinus arrest, or other cardiac arrhythmias

Locations

Location

Status

Recruiting